Widely used:Recently Viewed
Clear All$14.21
$-0.03
(-0.21%)
As on 18-Jun-2025 16:10EDT
Today’s Range
52 Week Range
Liquidity
Market cap
$1,459 Mln
Revenue (TTM)
$-- Mln
Net Profit (TTM)
$-- Mln
ROE
0 %
ROCE
-- %
P/E Ratio
68.6
P/B Ratio
0.9
Industry P/E
--
EV/EBITDA
0
Div. Yield
14.1 %
Debt to Equity
--
Book Value
$--
EPS
$--
Face value
--
Shares outstanding
101,255,000
CFO
$--
EBITDA
$--
Net Profit
$--
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
BlackRock Health Sciences Trust II of Beneficial Interest (BMEZ)
| -1.3 | -1.9 | -7.1 | -5.7 | -2.6 | -6.9 | -- |
|
BSE Sensex
| 4.1 | -1.1 | 9.8 | 5.8 | 16.6 | 19.4 | 11.7 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2024
|
2023
|
2022
|
2021
|
|---|---|---|---|---|
|
BlackRock Health Sciences Trust II of Beneficial Interest (BMEZ)
| -1.7 | -5.1 | -39.2 | -6.3 |
|
S&P Small-Cap 600
| 7.0 | 13.9 | -17.4 | 25.3 |
|
BSE Sensex
| 8.1 | 18.7 | 4.4 | 22.0 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
BlackRock Health Sciences Trust II of Beneficial Interest (BMEZ)
|
14.2 | 1,459.1 | -- | -- | -- | -- | 68.6 | 0.9 |
| 14.8 | 1,559.1 | 197.7 | 194.4 | -- | 10.9 | 8 | 0.9 | |
| 7.1 | 1,719.5 | 40.7 | 35.7 | -- | 1.9 | 9.1 | 0.9 | |
| 21.6 | 1,417.9 | 84.2 | 46.7 | 170.8 | 2.9 | 36 | 0.9 | |
| 20.6 | 5,929.0 | 1,055.0 | 532.0 | 72.1 | 8.1 | 11.2 | 0.9 | |
| 12.3 | 2,110.7 | 1,167.5 | 929.7 | 112.4 | 43 | 2.3 | 0.8 | |
| 13.3 | 1,716.1 | 30.7 | 30.6 | -- | 2.1 | 6.4 | 1.1 | |
| 3.2 | 1,485.6 | 145.1 | -244.4 | -253.6 | -5.8 | -- | 0.5 | |
| 17.1 | 1,654.9 | 550.3 | 547.4 | -- | 29.2 | 3 | 0.8 | |
| 30.6 | 1,599.9 | 321.7 | 320.8 | -- | 17.6 | 5 | 0.9 |
Address: 50 Hudson Yards, New York, NY, United States, 10001
Portfolio Mang.
Mr. Jeffrey Gene Lee
Portfolio Manager
Dr. Xiang Liu Ph.D.
Headquarters
New York, NY
Website
--
Our rating system has guided millions of investors in the past 20 years.
The total asset value of BlackRock Health Sciences Trust II of Beneficial Interest (BMEZ) stood at -- as on 31-Dec-22
The share price of BlackRock Health Sciences Trust II of Beneficial Interest (BMEZ) is $14.21 (NYSE) as of 18-Jun-2025 16:10 EDT. BlackRock Health Sciences Trust II of Beneficial Interest (BMEZ) has given a return of -2.58% in the last 3 years.
BlackRock Health Sciences Trust II of Beneficial Interest (BMEZ) has a market capitalisation of $ 1,459 Mln as on 17-Jun-2025. As per Value Research classification, it is a Small Cap company.
The P/E ratio of BlackRock Health Sciences Trust II of Beneficial Interest (BMEZ) is 68.62 times as on 17-Jun-2025.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the BlackRock Health Sciences Trust II of Beneficial Interest (BMEZ) and enter the required number of quantities and click on buy to purchase the shares of BlackRock Health Sciences Trust II of Beneficial Interest (BMEZ).
Address: 50 Hudson Yards, New York, NY, United States, 10001
The CEO & director of Mr. Jeffrey Gene Lee. is BlackRock Health Sciences Trust II of Beneficial Interest (BMEZ), and CFO & Sr. VP is Dr. Xiang Liu Ph.D..
There is no promoter pledging in BlackRock Health Sciences Trust II of Beneficial Interest (BMEZ).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
602
|
|
|
209
|
|
|
172
|
|
|
172
|
|
|
168
|
|
|
165
|
|
|
159
|
|
|
152
|
|
|
142
|
| BlackRock Health Sciences Trust II of Beneficial Interest (BMEZ) | Ratios |
|---|---|
|
Return on equity(%)
|
--
|
|
Operating margin(%)
|
--
|
|
Net Margin(%)
|
--
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of BlackRock Health Sciences Trust II of Beneficial Interest (BMEZ) was No Profit.
